SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+24.5%
5Y CAGR+49.6%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+24.5%/yr
Annual compound
5Y CAGR
+49.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
7.5x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 23.00 | +41.8% |
| 2024 | 16.22 | +80.7% |
| 2023 | 8.97 | -24.8% |
| 2022 | 11.92 | -4.8% |
| 2021 | 12.53 | +308.1% |
| 2020 | 3.07 | -35.1% |
| 2019 | 4.73 | - |